KR850002954A - 젤라틴 캡슐 - Google Patents

젤라틴 캡슐 Download PDF

Info

Publication number
KR850002954A
KR850002954A KR1019840001066A KR840001066A KR850002954A KR 850002954 A KR850002954 A KR 850002954A KR 1019840001066 A KR1019840001066 A KR 1019840001066A KR 840001066 A KR840001066 A KR 840001066A KR 850002954 A KR850002954 A KR 850002954A
Authority
KR
South Korea
Prior art keywords
dosage unit
sorbitol
weight
unit form
antiembrittlement
Prior art date
Application number
KR1019840001066A
Other languages
English (en)
Other versions
KR890000117B1 (ko
Inventor
브록스 워너
Original Assignee
원본미기재
알·피·세러 코오포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10538838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR850002954(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 원본미기재, 알·피·세러 코오포레이숀 filed Critical 원본미기재
Publication of KR850002954A publication Critical patent/KR850002954A/ko
Application granted granted Critical
Publication of KR890000117B1 publication Critical patent/KR890000117B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

젤라틴 캡슐
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 소르비톨 및 한 개 이상의 소르비탄류의 혼합물을 포함하는 취화(脆化)방지용 조성물 및 젤라틴, 가소화제를 함유하는 연질젤라틴 캡술내에서, 캡슐화되며 액체 폴리에틸렌 글리콜내에 용해 또는 현탁되는 한 개이상의 제약학적 활성재료를 함유하는 제약학적 복용단위 형태
  2. 제1항에 있어서, 취화방지용 조성물은 물 및 기타 다가알코올류와 함께 25-40중량%의 소르비톨과 20-30중량%의 소르비탄류를 함유하는 복용단위 형태.
  3. 제2항에 있어서, 취화방지용 조성물은 만니톨을 6중량% 이상 함유하지않는 복용단위 형태.
  4. 제1항에 있어서, 껍질은 소르비톨/소르비탄 혼합물을 4-25중량% 함유하는 복용단위 형태.
  5. 제1항에 있어서, 폴리에틸렌글리콜은 또한 글리세린, 소르비톨 또는 프로필렌 글리콜은 함유하는 복용단위 형태.
  6. 제5항에 있어서, 글리세린, 소르비톨 또는 프로필렌 글리콜은 1-20중량%로 폴리에틸렌 글리콜내에 존재하는 복용단위 형태.
  7. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840001066A 1983-03-02 1984-03-02 젤라틴 캡슐 KR890000117B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8305693 1983-03-02
GB838305693A GB8305693D0 (en) 1983-03-02 1983-03-02 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
KR850002954A true KR850002954A (ko) 1985-05-28
KR890000117B1 KR890000117B1 (ko) 1989-03-08

Family

ID=10538838

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840001066A KR890000117B1 (ko) 1983-03-02 1984-03-02 젤라틴 캡슐

Country Status (14)

Country Link
US (1) US4780316A (ko)
EP (1) EP0121321B1 (ko)
JP (1) JPH06695B2 (ko)
KR (1) KR890000117B1 (ko)
AT (1) ATE65023T1 (ko)
AU (1) AU566832B1 (ko)
CA (1) CA1211049A (ko)
DE (1) DE3484779D1 (ko)
DK (1) DK162875C (ko)
ES (1) ES8503508A1 (ko)
FI (1) FI79244C (ko)
GB (1) GB8305693D0 (ko)
NO (1) NO840793L (ko)
WO (1) WO1984003416A1 (ko)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030632A (en) * 1986-09-23 1991-07-09 Sandoz Pharm. Corp. Low dose temazepam
US5211954A (en) * 1986-09-23 1993-05-18 Sandoz Ltd. Low dose temazepam
US5629310A (en) * 1986-09-23 1997-05-13 Sterling; William R. Low dose temazepam
CH673947A5 (ko) * 1986-09-23 1990-04-30 Sandoz Ag
GB8701332D0 (en) * 1987-01-21 1987-02-25 Lilly Industries Ltd Capsule filling
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
US5447966A (en) * 1988-07-19 1995-09-05 United States Surgical Corporation Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5200191A (en) * 1991-09-11 1993-04-06 Banner Gelatin Products Corp. Softgel manufacturing process
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
ES2308955T5 (es) * 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
FR2728464B1 (fr) 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US6077513A (en) * 1996-05-02 2000-06-20 Massoud; Ahmed Mohamed Ali Drug for treatment of bilharziasis (Schistosomiasis)
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
CN1183904C (zh) * 1999-02-26 2005-01-12 盐野义制药株式会社 改进了服用性的咀嚼型软胶囊剂及其制法
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US20030124225A1 (en) * 1999-11-01 2003-07-03 Paul West Encapsulated alcoholic beverage
US20030034458A1 (en) * 2001-03-30 2003-02-20 Fuji Photo Film Co., Ltd. Radiation image storage panel
US6752953B2 (en) * 2001-12-03 2004-06-22 Yung Shin Pharmaceutical Co., Ltd. Method for manufacturing hard non-gelatin pharmaceutical capsules
JP4995407B2 (ja) 2002-04-25 2012-08-08 バナー ファーマキャップス， インコーポレーテッド 咀嚼可能なソフトカプセル
US20050058703A1 (en) * 2003-08-01 2005-03-17 Chang Robert C. Gelatin capsules
US20050230871A1 (en) * 2004-04-20 2005-10-20 Bess William S Fast-dissolving films
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
US20060153824A1 (en) * 2005-01-13 2006-07-13 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US7485609B2 (en) * 2005-09-29 2009-02-03 Kimberly-Clark Worldwide, Inc. Encapsulated liquid cleanser
US20070134493A1 (en) * 2005-12-08 2007-06-14 Kanji Meghpara Compositions and capsules with stable hydrophilic layers
CA2637275C (en) 2006-01-24 2014-12-09 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
RU2420291C3 (ru) * 2006-01-24 2020-07-21 Р-Тек Уено, Лтд. Состав в мягкой желатиновой капсуле
US20090110724A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of pain
US20100285121A1 (en) * 2008-01-10 2010-11-11 Takeda Pharmaceutical Company Limited Capsule Formulation
US20090214641A1 (en) * 2008-02-26 2009-08-27 Joar Opheim Sweetened Capsules for Administration
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
CA2726267C (en) 2008-06-06 2017-10-31 Boehringer Ingelheim International Gmbh Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
US8621764B2 (en) 2011-03-16 2014-01-07 John PUCKETT Gelatin capsule formulation and drying system
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
CN102225055B (zh) * 2011-06-14 2012-05-23 贵州地道药业有限公司 一种软胶囊囊壳配方
AU2012324013A1 (en) * 2011-11-03 2013-05-23 Gtx, Inc. Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof
KR101466617B1 (ko) * 2011-11-17 2014-11-28 한미약품 주식회사 오메가-3 지방산 및 HMG-CoA 환원효소 억제제를 포함하는 안정성이 증가된 경구용 복합 제제
NZ700567A (en) * 2012-04-30 2016-10-28 Dow Agrosciences Llc Pesticide composition delivery vehicles
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
US20150335586A1 (en) 2014-05-20 2015-11-26 R.P. Scherer Technologies, Llc Capsule dispensing container
WO2016044805A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
EP3053598A1 (en) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules
JP6019204B1 (ja) * 2015-11-30 2016-11-02 三生医薬株式会社 ソフトカプセル剤
ITUB20156821A1 (it) 2015-12-09 2017-06-09 Altergon Sa CAPSULE DI GELATINA MOLLE A RILASCIO pH INDIPENDENTE
NL2017219B1 (en) 2016-07-22 2018-01-30 Rousselot B V Low cross-linking gelatine
US11911517B2 (en) * 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
TW202106280A (zh) * 2019-08-08 2021-02-16 英諾美生物科技股份有限公司 保存潤滑劑用之膠囊
US11583552B2 (en) 2021-02-17 2023-02-21 Manoj Maniar Pharmaceutical formulation of arsenic trioxide
EP4176724A1 (en) 2021-11-09 2023-05-10 Universität Hohenheim Use of an oleogel as a layer or coating

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2172357A (en) * 1938-01-29 1939-09-12 Atlas Powder Co Composition
GB715879A (en) * 1952-06-23 1954-09-22 Scherer Corp R P Improvements in or relating to gelatin capsule and method of making the same
US2870060A (en) * 1956-02-07 1959-01-20 Mead Johnson & Co Stable encapsulated solution of a salt of a dialkyl sulfosuccinate
US2870062A (en) * 1956-04-27 1959-01-20 Scherer Corp R P Gelatin composition for capsules
US2889252A (en) * 1956-05-14 1959-06-02 American Cyanamid Co Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
US2847346A (en) * 1956-11-20 1958-08-12 Lloyd Brothers Inc Laxative compositions contaqining dioctyl sodium sulfosuccinate and 1, 8-dihydroxyanthraquinone
DE1617629A1 (de) * 1966-11-09 1971-03-25 Merck Patent Gmbh Verfahren zur Stabilisierung von Bromelin in Arzneimittelzubereitungen
US3520971A (en) * 1966-12-05 1970-07-21 Scherer Corp R P Bath capsule
FR1599474A (ko) * 1968-12-27 1970-07-15
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3779942A (en) * 1970-12-04 1973-12-18 Minnesota Mining & Mfg Capsules and process for forming capsules
SU432703A3 (ko) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
BE825842A (fr) * 1974-02-22 1975-08-21 Compositions pharmaceutiques comprenant de la digoxine
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
ZA835226B (en) * 1982-07-19 1985-03-27 Syntex Inc Pge-type compositions encapsulated by acid isolated gelatin

Also Published As

Publication number Publication date
FI840832A (fi) 1984-09-03
FI840832A0 (fi) 1984-03-01
AU566832B1 (en) 1987-10-29
CA1211049A (en) 1986-09-09
DK146784A (da) 1984-09-03
JPS60500867A (ja) 1985-06-06
JPH06695B2 (ja) 1994-01-05
EP0121321A2 (en) 1984-10-10
ES530270A0 (es) 1985-03-16
EP0121321B1 (en) 1991-07-10
DK162875B (da) 1991-12-23
WO1984003416A1 (en) 1984-09-13
FI79244B (fi) 1989-08-31
DE3484779D1 (de) 1991-08-14
DK162875C (da) 1992-05-18
US4780316A (en) 1988-10-25
EP0121321A3 (en) 1986-01-29
NO840793L (no) 1984-09-03
ES8503508A1 (es) 1985-03-16
DK146784D0 (da) 1984-02-29
KR890000117B1 (ko) 1989-03-08
GB8305693D0 (en) 1983-04-07
ATE65023T1 (de) 1991-07-15
FI79244C (fi) 1989-12-11

Similar Documents

Publication Publication Date Title
KR850002954A (ko) 젤라틴 캡슐
FI871594A0 (fi) Gelatinkapslar och deras framstaellningsfoerfarande.
ATE42463T1 (de) Polyethylenglykolhaltige weichgelatinekapsel und verfahren zu ihrer herstellung.
DK0649651T3 (da) Fremstilling af bløde gelatinekapsler
ES8201419A1 (es) Un metodo para preparar una solucion acuosa de nitrogliceri-na
KR850004389A (ko) 경피침투가 증진된 생리학적 활성제제의 제조방법
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
KR850002377A (ko) 살충제 조성물
KR840000234A (ko) (n-아세틸-파라-아미노페놀)-제산제 조성물
KR830004849A (ko) 약학적 제제의 제조방법
KR970073593A (ko) 진세노사이드 Rg_5를 함유하는 항암제 조성물
JPS53139716A (en) Pharmaceutical preparation of stable prostaglandine
JPS5359095A (en) Preparation of 7-aminocephem cpds.
JPS52130905A (en) Medicinal composition
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
KR850007455A (ko) 납(로우)모형용왁스 혼합물
GB563011A (en) Sealed capsules
JPS5688758A (en) Chewing gum containing dextranase and its production
KR840002607A (ko) 살서제 조성물
JPS5695114A (en) Carcinostatic agent
JPS51120223A (en) Halogenized silver color photosensitive materials
JPS52151160A (en) Preparation of novel 1-phthalimido-alkanediones
KR830004778A (ko) 살충제 조성물
KR890700580A (ko) 진경 작용을 갖는 제약 조성물
KR960000246A (ko) 사이클로스포린 함유 액제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030304

Year of fee payment: 15

EXPY Expiration of term